We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GRVI market cap is 103.4M. The company's latest EPS is USD -1.1326 and P/E is -4.13.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 17.81M | 27.35M | 21.83M | 10.41M | -33.59M |
| Operating Income | -3.79M | -1.14M | -1.79M | -5.04M | -13.64M |
| Net Income | -15.36M | -1.36M | -2.44M | -4.12M | -15.75M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.41M | 24.1M | 44.59M | 80.68M | 26M |
| Operating Income | -4.84M | 1.8M | -2.65M | -11.3M | -21.6M |
| Net Income | -5.38M | 2.98M | -2.1M | -16.93M | -23.66M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 63.85M | 65.25M | 62.16M | 56.51M | 23.51M |
| Total Liabilities | 36.02M | 37.68M | 36.7M | 34.45M | 17M |
| Total Equity | 27.84M | 27.57M | 25.46M | 22.06M | 6.52M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.4M | 27.25M | 48.49M | 63.85M | 23.51M |
| Total Liabilities | 4.22M | 6.04M | 19.7M | 36.02M | 17M |
| Total Equity | 2.18M | 21.22M | 28.79M | 27.84M | 6.52M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 203k | -2.34M | -2.34M | -3.03M | -101k |
| Investing | -2.58M | -649k | -902k | -401k | -3.38M |
| Financing | -286k | -1.08M | 598k | -559k | -354k |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.16M | 2.94M | 522k | 203k | -101k |
| Investing | -1.46M | -1.28M | -11.61M | -2.58M | -3.38M |
| Financing | 2.82M | 11.99M | 3.7M | -286k | -354k |
| Market Cap | 103.4M |
| Price to Earnings Ratio | -4.13 |
| Price to Sales Ratio | 3.76 |
| Price to Cash Ratio | 148.1 |
| Price to Book Ratio | 15 |
| Dividend Yield | - |
| Shares Outstanding | 20.89M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.18 (20.42%) |
| Company Name | Grove Inc |
| Address |
3773 howard hughes pkwy las vegas, nevada 89169 6014 |
| Website | https://upexi.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
